Source: International Congress 2016 – Asthma: mechanisms and biomarkers that promote clinical understanding
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Jinrui Dong (Singapore, Singapore), Jinrui Dong, Wupeng Liao, Hong Yong Peh, Tze Khee Chan, W.S. Daniel Tan, Li Li, W.S. Fred Wong. Ribosomal protein S3 gene silencing protects against experimental allergic asthma. Eur Respir J 2016; 48: Suppl. 60, 562

Member's Comments

No comment yet.

Related content which might interest you: QGE031 (ligelizumab) is more effective than omalizumab and placebo in inhibiting allergen-induced early asthmatic response: Results from a predictive modeling study Source: International Congress 2015 – Asthma mechanisms and management Year: 2015 Expression of genes associated with neurogenic inflammation in pediatric asthma Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules Year: 2013 Effect of ADRB2 gene polymorphism on treatment outcomes in asthmatics: Cold airway hyperresponsiveness and asthma control Source: International Congress 2014 – Genetics and environmental factors underlying asthma and COPD Year: 2014 Gene set variation analysis of mRNA expression in bronchial biopsies from the U-BIOPRED asthma study Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases Year: 2014 The homologous IL-17 cytokines A and F differentially regulate allergic asthma in murine models Source: International Congress 2015 – Advances in asthma and allergy in animal models Year: 2015 An antedrug of the CXCL12 neutraligand blocks experimental allergic asthma without systemic effect in the mouse Source: Annual Congress 2013 –Novel drugs for the treatment of asthma and COPD Year: 2013 Treatment with Syk inhibitors after establishment of disease phenotype in a chronic HDM model of allergic airways inflammation abolishes AHR and attenuates inflammatory mediator expression Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD Year: 2015 Polymorphisms in all three ORMDL genes are associated with asthma and their mRNA expression is increased in asthmatics Source: International Congress 2014 – Paediatric asthma: pathogenesis and immunology Year: 2014 Lung specific induction of Wnt-1 has a prophylactic and therapeutic effect on the development of an allergic airway disease Source: Annual Congress 2013 –Murine models of lung immunology Year: 2013 Preventative administration of IL-27 improves airway inflammation of ovalbumin –induced asthma mice model via both STAT1 and GADD45γ/p38MAPK pathways Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma Year: 2016 B cells in a murine model of allergic asthma and respiratory tolerance Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions Year: 2015 Oral administration of saccharomyces cerevisiae inhibits the allergic airway response in mice Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases Year: 2013 Mast cell gene signature enrichment associates with late-onset severe asthma Source: International Congress 2016 – Phenotyping asthma Year: 2016 Species comparison of interleukin-13 induced airway hyperreactivity as model for allergic asthma Source: International Congress 2014 – Animal models in respiratory drug development Year: 2014 Over-expression of the LTC4 synthase gene in mice reproduces human aspirin-induced asthma (AIA) Source: Annual Congress 2013 –Genetics and mechanisms of, and tests for, allergy Year: 2013 Mapping a mouse model of severe asthma to human asthma using gene set variation analysis Source: International Congress 2015 – Advances in the future treatment of severe asthma Year: 2015 Effect of TRPV4 gene polymorphisms on osmotic airway hyperresponsiveness in patients with asthma Source: International Congress 2015 – Genetics and environmental factors in phenotypes of asthma and COPD Year: 2015 Global evaluation of treatment effectiveness (GETE) is an accurate predictor of response to omalizumab in patients with severe allergic asthma: A pooled analysis Source: International Congress 2014 – Intervening in allergic asthma Year: 2014 Activation of the β-catenin pathway by Wnt-1 treatment suppress inflammation in the mouse model of allergic airway disease Source: International Congress 2015 – Advances in asthma and allergy in animal models Year: 2015 The immunomodulatory activity of protein S protects against allergic airway inflammation Source: International Congress 2015 – Immune mechanisms in the human lung Year: 2015